JRS
Nuveen Real Estate Income Fund [JRS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
JRS Stock Summary
Top 10 Correlated ETFs
JRS
Top 10 Correlated Stocks
JRS
In the News
JRS Financial details
Company Rating
Buy
Market Cap
212.36M
Income
22.85M
Revenue
12.93M
Book val./share
8.84
Cash/share
0.73
Dividend
0.68
Dividend %
8.77%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-1.81
Forward P/E
-
PEG
0.15
P/S
-1.82
P/B
0.95
P/C
9.88
P/FCF
3.57
Quick Ratio
4.35
Current Ratio
4.35
Debt / Equity
0.39
LT Debt / Equity
0.39
-
-
EPS (TTM)
0.79
EPS next Y
-
EPS next Q
-
EPS this Y
-133.1%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-11.72%
Revenue last 5Y
-11.73%
Revenue Q/Q
30.92%
EPS Q/Q
4.35%
-
-
-
-
SMA20
-12.5%
SMA50
-12.5%
SMA100
-
Inst Own
13.17%
Inst Trans
0.87%
ROA
-36%
ROE
-40%
ROC
-0.35%
Gross Margin
100%
Oper. Margin
98%
Profit Margin
100%
Payout
-20%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.95-8.0
52W High
-9.88%
52W Low
+44.2%
RSI
35
Rel Volume
0.06
Avg Volume
86.18K
Volume
5.01K
Perf Week
-2.83%
Perf Month
-8.85%
Perf Quarter
20.97%
Perf Half Y
8.1%
-
-
-
-
Beta
1.241
-
-
Volatility
0.1%, 0.24%
Prev Close
1.26%
Price
7.21
Change
0.42%
JRS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.65 | -0.94 | 4.35 | -4.25 | 1.42 | |
| Net income per share | 2.63 | -0.95 | 4.34 | -4.26 | 1.41 | |
| Operating cash flow per share | 0.65 | 1.42 | -0.42 | 2.17 | 0.85 | |
| Free cash flow per share | 0.65 | 1.42 | -0.42 | 2.17 | 0.85 | |
| Cash per share | 0.35 | 0.13 | 0.81 | 0.03 | 0.73 | |
| Book value per share | 11.35 | 9.63 | 13.22 | 8.12 | 8.84 | |
| Tangible book value per share | 11.35 | 9.63 | 13.22 | 8.12 | 8.84 | |
| Share holders equity per share | 11.35 | 9.63 | 13.22 | 8.12 | 8.84 | |
| Interest debt per share | 4.68 | 3.85 | 5.02 | 3.72 | 3.6 | |
| Market cap | 306.84M | 243.85M | 370.4M | 218.43M | 225.94M | |
| Enterprise value | 438.34M | 353.85M | 514.4M | 326.51M | 324.44M | |
| P/E ratio | 4.03 | -8.85 | 2.95 | -1.77 | 5.55 | |
| Price to sales ratio | 4.01 | -8.95 | 2.95 | -1.78 | 5.51 | |
| POCF ratio | 16.27 | 5.95 | -30.76 | 3.48 | 9.2 | |
| PFCF ratio | 16.27 | 5.95 | -30.76 | 3.48 | 9.2 | |
| P/B Ratio | 0.94 | 0.88 | 0.97 | 0.93 | 0.88 | |
| PTB ratio | 0.94 | 0.88 | 0.97 | 0.93 | 0.88 | |
| EV to sales | 5.73 | -12.99 | 4.09 | -2.66 | 7.92 | |
| Enterprise value over EBITDA | 5.76 | -12.85 | 4.1 | -2.72 | 7.97 | |
| EV to operating cash flow | 23.24 | 8.63 | -42.72 | 5.21 | 13.21 | |
| EV to free cash flow | 23.24 | 8.63 | -42.72 | 5.21 | 13.21 | |
| Earnings yield | 0.25 | -0.11 | 0.34 | -0.56 | 0.18 | |
| Free cash flow yield | 0.06 | 0.17 | -0.03 | 0.29 | 0.11 | |
| Debt to equity | 0.4 | 0.4 | 0.38 | 0.45 | 0.39 | |
| Debt to assets | 0.28 | 0.28 | 0.27 | 0.31 | 0.28 | |
| Net debt to EBITDA | 1.73 | -3.99 | 1.15 | -0.9 | 2.42 | |
| Current ratio | 7.74 | 70.55 | 23.52 | 4.35 | 4.6 | |
| Interest coverage | 20.72 | -21.12 | 139.03 | -39.76 | 7.38 | |
| Income quality | 0.25 | -1.49 | -0.1 | -0.51 | 0.6 | |
| Dividend Yield | 0.07 | 0.09 | 0.06 | 0.11 | 0.09 | |
| Payout ratio | 0.29 | -0.8 | 0.17 | -0.2 | 0.48 | |
| Sales general and administrative to revenue | 0 | -0.01 | 0 | 0 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 25.93 | 14.37 | 35.94 | 27.9 | 16.74 | |
| ROIC | 0.15 | -0.09 | 0.23 | -0.39 | 0.11 | |
| Return on tangible assets | 0.16 | -0.07 | 0.24 | -0.36 | 0.11 | |
| Graham Net | -4.26 | -3.86 | -4.28 | -3.66 | -2.73 | |
| Working capital | 1.76M | 3.37M | 1.82M | 1.48M | 1.58M | |
| Tangible asset value | 327.79M | 278.29M | 381.81M | 234.5M | 255.55M | |
| Net current asset value | -132.49M | -114.44M | -146.37M | -104.48M | -99.47M | |
| Invested capital | 0.4 | 0.4 | 0.38 | 0.45 | 0.39 | |
| Average receivables | 2.11M | 2.72M | 2.66M | 1.91M | 1.97M | |
| Average payables | 151.44K | 154.69K | 64.64K | 260.81K | 440.55K | |
| Average inventory | 0 | 0 | 0 | -1.84M | -1.84M | |
| Days sales outstanding | 9.64 | -45.76 | 5.52 | -5.7 | 18.03 | |
| Days payables outstanding | 24.05 | 5.29 | 7.33 | 42.36 | 53.76 | |
| Days of inventory on hand | 0 | 0 | 0 | -353.6 | 0 | |
| Receivables turnover | 37.85 | -7.98 | 66.14 | -64.04 | 20.25 | |
| Payables turnover | 15.17 | 68.96 | 49.8 | 8.62 | 6.79 | |
| Inventory turnover | 0 | 0 | 0 | -1.03 | 0 | |
| ROE | 0.23 | -0.1 | 0.33 | -0.53 | 0.16 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.14 | -0.13 | 0.13 | 0.19 | 0.25 | |
| Net income per share | -0.48 | -0.96 | 0.34 | 0.69 | 0.72 | |
| Operating cash flow per share | 0.62 | 0.18 | 0.24 | 0.18 | 0.17 | |
| Free cash flow per share | 0.62 | 0.18 | 0.24 | 0.18 | 0.17 | |
| Cash per share | 0.13 | 0.03 | 0.14 | 0.21 | 0.73 | |
| Book value per share | 8.12 | 8.12 | 8.46 | 8.46 | 8.84 | |
| Tangible book value per share | 8.12 | 8.12 | 8.46 | 8.46 | 8.84 | |
| Share holders equity per share | 8.12 | 8.12 | 8.46 | 8.46 | 8.84 | |
| Interest debt per share | 0 | 3.69 | 0 | 3.36 | 3.51 | |
| Market cap | 223.34M | 218.43M | 215.83M | 214.67M | 225.94M | |
| Enterprise value | 227.02M | 326.51M | 219.76M | 313M | 324.44M | |
| P/E ratio | -4.02 | -1.96 | 5.42 | 2.7 | 2.72 | |
| Price to sales ratio | 55.45 | -58.73 | 55.96 | 38.74 | 31.15 | |
| POCF ratio | 12.44 | 42.85 | 31.06 | 41.69 | 47.04 | |
| PFCF ratio | 12.44 | 42.85 | 31.06 | 41.69 | 47.04 | |
| P/B Ratio | 0.95 | 0.93 | 0.88 | 0.88 | 0.88 | |
| PTB ratio | 0.95 | 0.93 | 0.88 | 0.88 | 0.88 | |
| EV to sales | 56.36 | -87.79 | 56.98 | 56.49 | 44.72 | |
| Enterprise value over EBITDA | -13.32 | -12.74 | 31.87 | 13.89 | 13.7 | |
| EV to operating cash flow | 12.64 | 64.05 | 31.62 | 60.78 | 67.54 | |
| EV to free cash flow | 12.64 | 64.05 | 31.62 | 60.78 | 67.54 | |
| Earnings yield | -0.06 | -0.13 | 0.05 | 0.09 | 0.09 | |
| Free cash flow yield | 0.08 | 0.02 | 0.03 | 0.02 | 0.02 | |
| Debt to equity | 0 | 0.45 | 0 | 0.39 | 0.39 | |
| Debt to assets | 0 | 0.31 | 0 | 0.27 | 0.28 | |
| Net debt to EBITDA | -0.22 | -4.22 | 0.57 | 4.36 | 4.16 | |
| Current ratio | 0.1 | 4.35 | 0.15 | 0.32 | 4.6 | |
| Interest coverage | 0 | -11.78 | 0 | 8.53 | 8.24 | |
| Income quality | -1.29 | -0.18 | 0.7 | 0.26 | 0.23 | |
| Dividend Yield | 0.04 | 0.08 | 0.01 | 0.02 | 0.06 | |
| Payout ratio | -0.65 | -0.65 | 0.25 | 0.25 | 0.7 | |
| Sales general and administrative to revenue | 0.22 | -0.24 | 0.21 | 0.15 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 9.37 | 13.25 | 8.1 | 11.45 | 11.97 | |
| ROIC | 0 | -0.08 | 0 | 0.06 | 0.07 | |
| Return on tangible assets | -0.04 | -0.08 | 0.03 | 0.06 | 0.06 | |
| Graham Net | -3.57 | -3.66 | -3.43 | -3.35 | -2.73 | |
| Working capital | -96.15M | 1.48M | -86.54M | -3.52M | 1.58M | |
| Tangible asset value | 234.5M | 234.5M | 244.57M | 244.57M | 255.55M | |
| Net current asset value | -96.15M | -104.48M | -86.54M | -100.6M | -99.47M | |
| Invested capital | 0 | 0.45 | 0 | 0.39 | 0.39 | |
| Average receivables | 1.75M | 1.92M | 1.79M | 1.66M | 0 | |
| Average payables | 3.05M | 220.38K | 220.38K | 2.59M | 0 | |
| Average inventory | -2.57M | -3.68M | -3.8M | -3.93M | 0 | |
| Days sales outstanding | 42.87 | -46.43 | 38.82 | 27.02 | 25.11 | |
| Days payables outstanding | 0 | 23.34 | 0 | 304.76 | 27.14 | |
| Days of inventory on hand | 0 | -194.81 | 0 | -231.14 | 0 | |
| Receivables turnover | 2.1 | -1.94 | 2.32 | 3.33 | 3.58 | |
| Payables turnover | 0 | 3.86 | 0 | 0.3 | 3.32 | |
| Inventory turnover | 0 | -0.46 | 0 | -0.39 | 0 | |
| ROE | -0.06 | -0.12 | 0.04 | 0.08 | 0.08 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
JRS Frequently Asked Questions
What is Nuveen Real Estate Income Fund stock symbol ?
Nuveen Real Estate Income Fund is a US stock , located in Chicago of Il and trading under the symbol JRS
What is Nuveen Real Estate Income Fund stock quote today ?
Nuveen Real Estate Income Fund stock price is $7.21 today.
Is Nuveen Real Estate Income Fund stock public?
Yes, Nuveen Real Estate Income Fund is a publicly traded company.
Company Profile
- Volume Average 86.18K
- Market Capitalization 212.36M
- CEO Mr. Anthony R. Manno Jr., CPA
- Headquarters Chicago,IL,US
- IPO Date 2001-11-19
-
Website
https://www.nuveen.com/CEF/FundDetail.aspx?FundCode=JRS 
Nuveen Real Estate Income Fund is a closed-ended equity mutual fund launched by Nuveen Investments Inc. The fund is managed by Security Capital Research & Management Incorporated. It invests in the public equity markets of the United States. The fund makes its investments in stocks of companies operating in the real-estate sector. It typically invests in growth stocks of companies operating across all market capitalizations. Nuveen Real Estate Income Fund was formed on November 15, 2001 and is domiciled in the United States.
